Reliable cognitive changes the first year following guideline-based treatment of isocitrate dehydrogenase mutated gliomas: A longitudinal multicenter study
Significant changes occurred in several cognitive domains after guideline-based treatment. Older age and chemoradiotherapy increased the risk of cognitive declines one year after surgery, but to which extent the deficits are persistent or progressing remains unknown.
Authors
- Louise Carstam (ORCID: https://orcid.org/0000-0001-6597-2570)
- Isabelle Rydén (ORCID: https://orcid.org/0000-0002-2384-9248)
- Anja Smits (ORCID: https://orcid.org/0000-0003-4171-2672)
- Per Hellström (ORCID: https://orcid.org/0000-0001-9803-7271)
- Alice Neimantaite (ORCID: https://orcid.org/0009-0004-0293-6707)
- Maria Zetterling (ORCID: https://orcid.org/0000-0003-4590-7063)
- Malin Blomstrand
- A. Lycett
- Åsa Alberius Munkhammar
- Asgeir Store Jakola (ORCID: https://orcid.org/0000-0002-2860-9331)
- Francesco Latini (ORCID: https://orcid.org/0000-0002-4702-526X)
- Dima Harba
Institutions
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1093/neuonc/noaf263
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer